ArticleEndocrine2026

Efficacy and safety of GLP-1 receptor agonists in the treatment of type 2 diabetes and/or obesity in patients with Cushing’s syndrome: a multicenter retrospective study.

Pedro Iglesias et al.PubMed ↗Publisher ↗

No numbers read from the abstract.